Browsing "1. College of Medicine (의과대학)" by Author : 4111

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 7 to 21 of 21

This table browses all dspace content
Issue DateTitleJournal Title
2009Management of BCG Failures in Non-Muscle-Invasive Bladder Cancer KOREAN JOURNAL OF UROLOGY
2019Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratioWORLD JOURNAL OF UROLOGY
2015Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP) BMC CANCER
2010Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy CANCER
2015Prognostic impact of synchronous second primary malignancies on the overall survival of patients with metastatic prostate cancerJOURNAL OF UROLOGY
2016Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers.RADIOLOGY
2014Role of targeting integrin-linked kinase in suppression of invasion and metastasis through downregulation of epithelial to mesenchymal transition in renal cell carcinoma Dissertation
2014Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasisJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2018Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate CancerJOURNAL OF UROLOGY
2015Targeting Integrin-Linked Kinase Suppresses Invasion and Metastasis through Downregulation of Epithelial-to-Mesenchymal Transition in Renal Cell CarcinomaMOLECULAR CANCER THERAPEUTICS
2015The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells BMC CANCER
2015The prognostic effect of prostate-specific antigen half-life at the first follow-up visit in newly diagnosed metastatic prostate cancerUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2024Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironmentNEURO-ONCOLOGY
2007신세포암의 현재 병기 체계에 대한 분석 및 재해석 Thesis
2007호르몬 불응성 전립선암에서 Estramustine을 기본으로 하는 항암화학요법 KOREAN JOURNAL OF UROLOGY
1

Browse

Links